Search - tctmd.com

Displaying 521 - 540 of 903

Sort: Relevancy | Date

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron

October 30, 2017

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Roman Tarasov

October 30, 2017

Presentation TCT 2017

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Presenter: Tony Das, Thomas Zeller

October 30, 2017

Presentation TCT 2017

Debate: Culprit Only and Deferred Revascularization in STEMI Should Be Routine

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Guy Witberg

October 29, 2017

Presentation TCT 2017

Debate: Early Complete Revascularization in STEMI Should Be Routine

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Mahmoud Idris Traina

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Giulio G. Stefanini

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

Presentation TCT 2017

Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker

October 29, 2017

Presentation TCT 2017

Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Adrian P. Banning

October 29, 2017

Presentation Stanford Coronary Physiology Conference 2017

Fuctional vs. Anatomic Complete Revascularization

Presenter: William F. Fearon

October 28, 2017

Presentation CDM 2017

Lower Extremity Revascularization A Critical Appraisal for Endovascular Therapy

Presenter: Lawrence A. Garcia

October 06, 2017

Presentation

Impact of Gender on Arterial Revascularization Strategies for CABG

September 29, 2017

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

Presentation CHIP Seattle 2017

Revascularization in Shock: Does it matter?

Presenter: Robert W. Yeh

August 11, 2017

Presentation CHIP Seattle 2017

When to Use Support for Complete Revascularization

Presenter: Ajay J. Kirtane

August 11, 2017

Presentation CHIP Seattle 2017

Inotropes and Drug Therapies for Shock: Data and Outcomes

Presenter: Sunil V. Rao

August 11, 2017

Presentation CHIP Seattle 2017

Unprotected Left Main Stenting and Complete Revascularization

Presenter: Paul Teirstein

August 11, 2017

Advertisement

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Debate: Culprit Only and Deferred Revascularization in STEMI Should Be Routine

Debate: Early Complete Revascularization in STEMI Should Be Routine

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care

Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients

Fuctional vs. Anatomic Complete Revascularization

Lower Extremity Revascularization A Critical Appraisal for Endovascular Therapy

Impact of Gender on Arterial Revascularization Strategies for CABG

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Revascularization in Shock: Does it matter?

When to Use Support for Complete Revascularization

Inotropes and Drug Therapies for Shock: Data and Outcomes

Unprotected Left Main Stenting and Complete Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content